Inicio>>Signaling Pathways>> Immunology/Inflammation>> CD73>>Oleclumab

Oleclumab

Catalog No.GC65470

Oleclumab (MEDI9447) es un anticuerpo monoclonal IgG1Λ anti-CD73 humano que inhibe la funciÓn de CD73. Oleclumab tiene actividad antitumoral.

Products are for research use only. Not for human use. We do not sell to patients.

Oleclumab Chemical Structure

Cas No.: 1803176-05-7

Tamaño Precio Disponibilidad Cantidad
1mg
522,00 $
Disponible
5mg
1.305,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Oleclumab (MEDI9447) is a human IgG1Λ anti-CD73 monoclonal antibody that inhibits CD73 function. Oleclumab has an anti-tumor activity[1].

[1]. Roy S Herbst, et al. COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer. J Clin Oncol. 2022 Apr 22;JCO2200227.

Reseñas

Review for Oleclumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Oleclumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.